Atherosclerotic diseases are the leading cause of mortality in Veteran population. Macrophages are the most prominent cell type in atherosclerotic lesions. The lipid-laden macrophages (foam cells) formation and subsequent inflammation in the arterial wall are the major pathogenesis for development of the diseases. Nuclear receptors have been reported to play a critical role in the lipid metabolism and inflammatory response. However, the regulation of their activity is unclear. It has been shown that there are major perturbations in cholesterol metabolism. The potential mechanisms by which such perturbations may lead to atherosclerosis via nuclear receptor signaling remain unclear. This knowledge gap in the field is a major barrier towards understanding the role of cholesterol metabolites in the pathogenesis of atherosclerosis and leveraging this information to develop novel therapies for atherosclerosis. We hypothesize that decreased SULT2B1b activity with consequent decreases in its metabolic product 25HC3S promotes atherosclerosis by (1) dysinhibition of the pro- lipogenic transcriptional factor, sterol response element binding protein-1c (SREBP-1c), due to failure to inactivate oxysterol signaling;and (2) disability of suppressing of inflammatory responses by decreasing IkB levels. These dysfunctions are caused by failure to regulate nuclear liver receptor homologue-1 (LRH-1). We will test the hypothesis by the following specific aims: 1). To explore that decreased SULT2B1b activity with consequent decreases in its metabolic product 25HC3S promotes atherosclerosis in vitro in free fatty acid-induced and in vivo high fat diet-induced atherosclerotc models. 2). To test potential of overexpression of SULT2B1b and administration 25HC3S to prevent/reverse lipid accumulation in blood and aortic wall in animal models. 3) To elucidate the molecular mechanism by which 25HC3S regulates LRH-1 activity: its role in lipid metabolism and inflammatory responses. These will provide a sufficient scientific background for development of new therapeutic strategies. The successful completion of the proposed studies will positively impact the field by: 1) providing a novel mechanism for the development of atherosclerosis, 2) identifying novel therapeutic targets for the treatment of atherosclerosis, and (3) opening new avenues of research focusing on the role of disordered cholesterol metabolism in the genesis and progression of atherosclerotic diseases.

Public Health Relevance

Atherosclerotic diseases are the leading cause of mortality in Veteran population. Macrophages are the most prominent cell type in atherosclerotic lesions. The lipid-laden macrophages (foam cells) formation and subsequent inflammation in the arterial wall are the major pathogenesis for development of the diseases. We hypothesize that decreased oxysterol sulfotransferase, SULT2B1b, activity with consequent decreases in its metabolic product 25HC3S promotes atherosclerosis. The overall goal of this proposal is to understand the molecular mechanism of oxysterol sulfation involved in the coordinate regulation of lipid metabolism and inflammatory responses, and to explore its clinical utility.

Agency
National Institute of Health (NIH)
Institute
Veterans Affairs (VA)
Type
Non-HHS Research Projects (I01)
Project #
5I01BX001874-02
Application #
8666531
Study Section
Cardiovascular Studies A (CARA)
Project Start
2013-07-01
Project End
2017-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
VA Veterans Administration Hospital
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23249
Min, Hae-Ki; Mirshahi, Faridoddin; Verdianelli, Aurora et al. (2015) Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 308:G794-803
Ren, Shunlin; Ning, Yanxia (2014) Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation. Am J Physiol Endocrinol Metab 306:E123-30
Shi, Xiongjie; Cheng, Qiuqiong; Xu, Leyuan et al. (2014) Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4?. Mol Cell Biol 34:485-97
Ren, Shunlin; Kim, Jin Koung; Kakiyama, Genta et al. (2014) Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3?,25-diol, disulfate. PLoS One 9:e103621
Xu, Leyuan; Shen, Shanwei; Ma, Yongjie et al. (2012) 25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPAR? signaling in human THP-1 macrophages. Am J Physiol Endocrinol Metab 302:E788-99
Zhang, Xin; Bai, Qianming; Xu, Leyuan et al. (2012) Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro. Am J Physiol Gastrointest Liver Physiol 303:G344-55
Zhang, Xin; Bai, Qianming; Kakiyama, Genta et al. (2012) Cholesterol metabolite, 5-cholesten-3?-25-diol-3-sulfate, promotes hepatic proliferation in mice. J Steroid Biochem Mol Biol 132:262-70
Rodriguez-Agudo, Daniel; Calderon-Dominguez, Maria; Medina, Miguel Angel et al. (2012) ER stress increases StarD5 expression by stabilizing its mRNA and leads to relocalization of its protein from the nucleus to the membranes. J Lipid Res 53:2708-15
Bai, Qianming; Zhang, Xin; Xu, Leyuan et al. (2012) Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease. Metabolism 61:836-45
Rodriguez-Agudo, Daniel; Calderon-Dominguez, Maria; Ren, Shunlin et al. (2011) Subcellular localization and regulation of StarD4 protein in macrophages and fibroblasts. Biochim Biophys Acta 1811:597-606